About James Blouzard
James Blouzard is a director of SymKardia, a medical device company working on cardiac neuromodulation therapy for people with arrhythmias. He is also a director of Nocionix, Inc.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name James Blouzard in the role, so the role may have started earlier or lasted longer.
SymKardia, Inc. Current
Director
2026 – Present · Westlake, OH
SymKardia is developing selective cardiac neuromodulation as a new way to treat patients with cardiac arrhythmias.
NI
Nocionix, Inc. Current
Director
Nocionix,Inc.
Director
2026 · Westlake, OH
Nocionix develops a nerve-based therapy for people with chronic pain that avoids hormones, surgery, and opioids.
Key Colleagues at Startups
The people James Blouzard works with at each company, as listed on that company's latest Form D.
Nocionix,Inc. · Form D, Nov 4, 2026
RP
Robert Picarel
Director
AS
Arun Sridhar
Director
CR
Claudio Rumazza
Executive officer and director
AC
Anthony Caparso
President and director
AC
Alain Garcinuno Collet
Director
TA
Tony Artiga
Director
SymKardia, Inc. · Form D/A, Oct 28, 2026
AC
Anthony Caparso
President and director
Bruce KenKnight
Chief Executive Officer
Steven Girouard
Executive officer
Jonathan Piccini
Executive officer
Imad Libbus
Chief Scientific Officer
Dwight Skinner
Executive officer
RP
Robert Picarel
Director
AS
Arun Sridhar
Director
CR
Claudio Rumazza
Director
AC
Alain Garcinuno Collet
Director